Enduro Genetics, a synthetic biology startup, raised €12 million ($12.4 million) in Series A funding from Supernova Invest, NOON Ventures, and Sandwater. The funding will be used to expand Enduro’s ...

Financing follows Torres's CrossBridge Bio acquisition by Eli Lilly and supports translation of ARTAN Bio's programmable approach to mutation-driven aging biology. ST. PETERSBURG, ...

A new study by UCLA Health published in Cell presents a major advancement in the future of personalized medicine by pinpointing new connections between people's genes, disease risk and medicine ...

A partnership between Novo Nordisk and Variant Bio will trigger financial benefits for partner communities across the world that share their genetic data. (iStock / Getty Images Plus) Looking to ...

Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like ...

Mo Khalil is the Hok Lam and Kathleen Kam Wong Professor of Bioengineering and Professor of Molecular and Cellular Biology at the Harvard John A. Paulson School of Engineering and Applied Sciences ...

Studies of genetics conducted in yeast cells, human neurons, mice or other model systems often reveal networks of genes that ...

A graph-based computational tool for detecting previously invisible genetic mutations has been developed. Researchers at the University of California, Los Angeles (UCLA; USA) and the University of ...

Engage Biologics Inc. (“Engage”), a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it has been acquired by Eli Lilly and Company (“Lilly”). Engage is ...

Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract their harmful molecular effects.